Tower Research Capital LLC (Trc) Abeona Therapeutics Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.07 Billion
- Q1 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Abeona Therapeutics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 16,140 shares of ABEO stock, worth $68,433. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,140
Previous 2,014
701.39%
Holding current value
$68,433
Previous $10,000
1070.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ABEO
# of Institutions
65Shares Held
14.4MCall Options Held
715KPut Options Held
58K-
Adage Capital Partners Gp, L.L.C. Boston, MA3.25MShares$13.8 Million0.05% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.31MShares$9.8 Million1.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.99MShares$8.42 Million0.01% of portfolio
-
Western Standard LLC Los Angeles, CA1.36MShares$5.77 Million4.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.1MShares$4.67 Million0.0% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $25.2M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...